Blog & Events

In honor of International Clinical Trials Day - a day dedicated to celebrating the vital contributions of clinical research professionals and organizations around the world - we sat down with our CRO’s CEO, Aurélie Weiss-Guimet, a clinical research professional with…

Would you like to learn more about ExperTrials? We have created a series of blog posts that are designed to let you know what our CRO is all about: its management style, its chosen size, and its market niche. In…

Glioblastoma is the most common malignant primary brain tumor in adults. Every year globally, more than 300,000 cases of glioblastoma are diagnosed (around 12,000 cases in the United States). The understanding of its biology has made considerable progress. However, therapeutic advances have…

Have you ever asked yourself how a small Contract Research Organization is run? We thought it would be worth explaining and decided it was a great opportunity to interview Aurélie Weiss-Guimet, our CEO and Founder (read her full portrait here). This…

ExperTrials was created in 2011 by Aurélie Weiss-Guimet (read her portrait here) and officially became a full-service CRO in 2019. The company’s core team includes eight members plus an operational team of 80 consultants across Europe with local expertise. It…

A new Annex, Annex III, has been included in version 6.3 of the Q&A guidance relating to CTR No 536/2014.   The new CTR NO 536/2014 deadline will enter into force on January 31, 2023, as will the Questions &…

The new CTR (Clinical Trial Regulation) No 536/2014 will repeal the existing Clinical Trial Directive No 2001/20CE on the 31st of January 2022. It’s impossible to summarize all changes that come along with this new regulation in one sentence, however